7.1 Sodium Homeostasis: Hyponatremia, Hypernatremia, SIADH & Diabetes Insipidus

7.1 Sodium Homeostasis: Hyponatremia, Hypernatremia, SIADH & Diabetes Insipidus

[!NOTE] Primary Extracellular Osmotic Determinant: Sodium (Na+) is the most abundant extracellular cation, comprising greater than 90% of all cations in extracellular fluid (ECF). Because cell membranes are freely permeable to water via aquaporin channels, sodium concentration dictates plasma tonicity and governs the distribution of water across fluid compartments. Consequently, clinical disorders of sodium concentration are fundamentally disorders of water balance (free water deficit or excess) rather than alterations in total-body sodium mass.

---

Sodium Physiology & Renal Tubular Handling

Under normal physiological conditions, serum sodium is maintained within an exceptionally narrow reference range of 136 to 145 mmol/L (or mEq/L). Total body sodium in a 70-kg adult is approximately 4,000 mmol, with roughly 70% readily exchangeable across the extracellular space and 30% bound within the crystalline hydroxyapatite matrix of bone.

+-----------------------------------------------------------------------------------------+
|                     Renal Tubular Sodium Handling & Transport Breakdown                 |
+-----------------------------------------------------------------------------------------+
| Segment               Fraction Reabsorbed   Primary Apical Transporter   Regulatory Driver|
+-----------------------------------------------------------------------------------------+
| Proximal Tubule       65% - 70%             NHE3 (Na+/H+ Exchanger),     Constitutive;    |
| (PCT)                 (Isotonic)            SGLT2/SGLT1 Cotransporters   Angiotensin II   |
|                                                                                         |
| Loop of Henle         20% - 25%             NKCC2 Cotransporter          Medullary counter-|
| (Thick Ascending)     (Water-impermeable)   (Na+-K+-2Cl- symporter)      current multiplier|
|                                                                                         |
| Distal Convoluted     5%                    NCC (Na+-Cl- Cotransporter)  Constitutive;    |
| Tubule (DCT)          (Diluting segment)                                 Thiazide target  |
|                                                                                         |
| Cortical Collecting   2% - 3%               ENaC (Epithelial Na+         Aldosterone;     |
| Duct (CCD)            (Fine-tuning)         Channel) on Principal Cells  Inhibited by ANP |
+-----------------------------------------------------------------------------------------+

Segmental Nephron Dynamics

1. Glomerular Filtration: In a healthy adult, approximately 180 liters of plasma are filtered daily, presenting roughly 25,000 mmol of sodium to the glomerulus. Greater than 99% of this filtered load must be reabsorbed to prevent fatal circulatory collapse.
2. Proximal Convoluted Tubule (PCT): Reabsorbs 65% to 70% of filtered sodium isotonically. Apical entry occurs via the Na+/H+ exchanger isoform 3 (NHE3) and Na+-glucose cotransporters (SGLT1 and SGLT2). Transport is energized by the basolateral Na+/K+-ATPase pump, which maintains a low intracellular sodium concentration (~10-12 mmol/L) and a negative membrane potential (-70 mV). Reabsorption of sodium in the PCT is stimulated by Angiotensin II and renal sympathetic nerve activity.
3. Loop of Henle (Thick Ascending Limb - TAL): Reabsorbs 20% to 25% of filtered sodium via the electroneutral NKCC2 (Na+-K+-2Cl-) cotransporter. Because the TAL is completely impermeable to water, solute reabsorption lowers tubular fluid osmolality to ~100-150 mOsm/kg while generating the hypertonic medullary interstitial gradient necessary for urine concentration. Loop diuretics (e.g., furosemide, bumetanide) inhibit NKCC2, abolishing this hypertonic gradient.
4. Distal Convoluted Tubule (DCT): Reabsorbs ~5% of filtered sodium via the electroneutral NCC (Na+-Cl-) cotransporter, which is inhibited by thiazide diuretics.
5. Cortical Collecting Duct (CCD): The final site for homeostatic fine-tuning, reabsorbing 2% to 3% of filtered sodium via apical Epithelial Sodium Channels (ENaC) on principal cells. Aldosterone binds to cytoplasmic mineralocorticoid receptors, translocates to the nucleus, and upregulates the transcription and cell-surface expression of ENaC and basolateral Na+/K+-ATPase. Potassium-sparing diuretics (e.g., amiloride, triamterene) directly plug the ENaC pore, whereas spironolactone and eplerenone antagonize mineralocorticoid receptors.

Endocrine Control: The ADH / Arginine Vasopressin (AVP) Axis

While aldosterone adjusts sodium reabsorption to regulate effective circulating volume, Arginine Vasopressin (AVP / ADH) governs water reabsorption to maintain plasma osmolality. Hypothalamic osmoreceptors detect subtle 1% to 2% shifts in extracellular osmolality above a baseline threshold of ~280-285 mOsm/kg, prompting the posterior pituitary to secrete ADH. ADH binds to V2 receptors on the basolateral membrane of collecting duct principal cells, activating adenylyl cyclase via Gs. The resulting rise in intracellular cyclic AMP (cAMP) activates Protein Kinase A (PKA), which phosphorylates and directs the exocytic insertion of Aquaporin-2 (AQP2) water channels into the apical plasma membrane. Water is reabsorbed down the medullary osmotic gradient into peritubular capillaries, yielding concentrated urine.

---

Diagnostic Evaluation of Hyponatremia (<136 mmol/L)

Hyponatremia is defined as a serum sodium concentration below 136 mmol/L. Severe hyponatremia (<120 mmol/L) is a medical emergency that carries substantial morbidity and mortality from central nervous system dysfunction.

+-----------------------------------------------------------------------------------------+
|                            Algorithmic Approach to Hyponatremia                         |
+-----------------------------------------------------------------------------------------+
|                                 [ Serum Sodium < 136 mmol/L ]                           |
|                                                |                                        |
|                                                v                                        |
|                                 Measure Measured Serum Osmolality                       |
|                   +----------------------------+---------------------------+            |
|                   v                            v                           v            |
|           [ High > 295 mOsm/kg ]      [ Normal 275-295 mOsm/kg ]    [ Low < 275 mOsm/kg ]|
|         Hypertonic Hyponatremia        Isotonic Hyponatremia         Hypotonic Hyponatr.|
|         - Severe Hyperglycemia         Pseudohyponatremia            (True Hyponatremia)|
|         - Mannitol Infusion            - Severe Hypertriglyceridemia       |            |
|                                        - Extreme Paraproteinemia           |            |
|                                                                            |            |
|     +--------------------------------------+-------------------------------+            |
|     v                                      v                               v            |
| [ Hypovolemic ]                     [ Euvolemic ]                  [ Hypervolemic ]     |
| Orthostasis, dry membranes          Normal turgor, no edema        Edema, ascites, JVD  |
| |-- Urine Na < 20: Extra-renal loss |-- SIADH (Urine Osm > 100,     |-- Urine Na < 20:    |
| |   (Vomiting, diarrhea, burns)     |   Urine Na > 20-40 mmol/L)    |   CHF, Cirrhosis,   |
| +-- Urine Na > 20: Renal loss       |-- Psychogenic Polydipsia      |   Nephrotic Syndr.  |
|     (Diuretics, Addison disease)    |   (Urine Osm < 100 mOsm/kg)   +-- Urine Na > 20:    |
|                                     +-- Hypothyroid, 2° Adrenal         Renal Failure   |
+-----------------------------------------------------------------------------------------+

Step 1: Establish True Hypotonicity vs Isotonic/Hypertonic Hyponatremia

Before investigating hormonal or volume etiologies, the clinical laboratory must exclude artifactual and translocational causes by measuring serum osmolality:

1. Hypertonic Hyponatremia (Measured Osmolality > 295 mOsm/kg): Caused by the accumulation of an unmeasured or measured osmotically active solute in the vascular compartment (most commonly glucose, or therapeutic infusions of mannitol or maltose). Hyperglycemia draws free water out of cells into the ECF along an osmotic gradient, diluting the extracellular sodium concentration.
   • The Katz Correction Formula: For every 100 mg/dL elevation in plasma glucose above normal (100 mg/dL), serum sodium drops by approximately 1.6 to 2.0 mmol/L:

     Corrected [Na+] = Measured [Na+] + 0.016 * (Serum Glucose [mg/dL] - 100)
     

     (Example: If measured [Na+] = 124 mmol/L and serum glucose is 700 mg/dL, the glucose excess is 600 mg/dL. The correction factor is 0.016 * 600 = 9.6 mmol/L, yielding a true corrected sodium of 124 + 9.6 = 133.6 mmol/L.)
2. Isotonic Hyponatremia / Pseudohyponatremia (Measured Osmolality 275 to 295 mOsm/kg):
   • Mechanism: The Electrolyte Exclusion Effect: Normal human plasma comprises approximately 93% aqueous phase (plasma water) and 7% non-aqueous solid phase (lipids and proteins). Electrolytes, including sodium, are dissolved exclusively within the plasma water.
   • Indirect Ion-Selective Electrode (ISE) vs Direct ISE:
     • Automated high-throughput clinical chemistry analyzers utilize indirect ISE, which dilutes patient serum with an aqueous buffer (typically 1:20 or 1:30) prior to analysis. The analyzer calculates electrolyte concentration by assuming a fixed 93% plasma water fraction.
     • In patients with profound hypertriglyceridemia (> 1,500 mg/dL, chylomicronemia) or severe monoclonal hyperproteinemia (multiple myeloma, Waldenström macroglobulinemia, total protein > 10-12 g/dL), the non-aqueous solid volume expands to 15% to 25% of total specimen volume. A fixed-volume pipetted aliquot contains less plasma water; dilution with reagent dilutes the electrolytes excessively, producing a falsely decreased reported sodium.
     • Direct ISE (employed on blood gas analyzers and point-of-care whole-blood analyzers) performs no pre-analytical dilution. The electrode directly contacts undiluted plasma water, measuring the true thermodynamic chemical activity (gamma * [Na+]). Direct ISE is immune to the electrolyte exclusion effect and reports a normal sodium concentration in pseudohyponatremia.

Step 2: Clinical & Laboratory Classification of Hypotonic Hyponatremia (<275 mOsm/kg)

Once true hypotonic hyponatremia is confirmed, patients are stratified by extracellular fluid (ECF) volume status and urinary biochemical markers:

A. Hypovolemic Hyponatremia

Characterized by a deficit in both total body sodium and total body water, with sodium loss exceeding water loss. Clinical features include postural hypotension, tachycardia, dry mucous membranes, and decreased skin turgor.

• Renal Sodium Wasting (Urine Na+ > 20 mmol/L, FENa > 1%):
  • Diuretic therapy: Thiazide diuretics are the most common cause. By blocking the Na+-Cl- cotransporter in the cortical diluting segment of the DCT, they promote sodium and water loss while impairing renal diluting capacity.
  • Mineralocorticoid deficiency (Primary Adrenal Insufficiency / Addison Disease): Destruction of the adrenal cortex eliminates aldosterone synthesis. Without aldosterone, the collecting duct principal cells fail to reabsorb sodium via ENaC, resulting in renal sodium wasting, severe hyperkalemia, and non-anion gap metabolic acidosis.
  • Cerebral salt wasting: Associated with subarachnoid hemorrhage or head trauma; excessive release of brain natriuretic peptide drives intense renal natriuresis.
• Extra-Renal Sodium Loss (Urine Na+ < 20 mmol/L, FENa < 1%):
  • The kidneys respond normally to systemic hypovolemia by maximally retaining sodium via intense aldosterone and sympathetic activation.
  • Etiologies include profuse vomiting, secretory diarrhea, excessive diaphoresis, severe burns, and third-spacing of fluids into non-functional compartments (acute pancreatitis, peritonitis, bowel obstruction).

B. Euvolemic Hyponatremia

Characterized by normal or near-normal extracellular volume, without peripheral edema or orthostatic hypotension.

• Syndrome of Inappropriate ADH Secretion (SIADH):
  • Pathophysiology: Unregulated, autonomous, non-osmotic release of ADH leads to continuous water retention, expanding total body water and causing dilutional hyponatremia. The mild subclinical volume expansion suppresses aldosterone and stimulates atrial natriuretic peptide (ANP), promoting persistent natriuresis.
  • Diagnostic Criteria:
    1. Serum hypoosmolality (< 275 mOsm/kg).
    2. Inappropriately concentrated urine (> 100 mOsm/kg, frequently exceeding 300-500 mOsm/kg despite severe plasma hypotonicity).
    3. Elevated urinary sodium (> 20 to 40 mmol/L) under conditions of normal dietary sodium intake.
    4. Clinical euvolemia (absence of edema, ascites, or orthostatic hypotension).
    5. Normal renal, adrenal (normal morning cortisol), and thyroid function (TSH normal).
  • Clinical Etiologies: Small cell lung carcinoma (ectopic ADH synthesis), CNS disorders (stroke, subdural hematoma, meningitis), pulmonary infections (tuberculosis, Legionella pneumonia), and medications (selective serotonin reuptake inhibitors [SSRIs], carbamazepine, cyclophosphamide, vincristine).
• Psychogenic Polydipsia (Primary Polydipsia):
  • Observed in patients with psychiatric conditions (schizophrenia) who consume massive volumes of free water (> 10 to 20 L/day), overwhelming the maximum renal excretory capacity (~12 to 15 L/day).
  • Laboratory Hallmark: Physiological suppression of ADH leads to maximally dilute urine: urine osmolality is < 100 mOsm/kg (often 50-70 mOsm/kg), urine specific gravity is < 1.003, and urine sodium is < 20 mmol/L. This contrasts sharply with SIADH.
• Secondary Adrenal Insufficiency: Isolated pituitary ACTH deficiency causes glucocorticoid (cortisol) deficiency. Because cortisol exerts physiological negative feedback on hypothalamic CRH and ADH secretion, hypocortisolism results in non-osmotic ADH disinhibition. Mineralocorticoid secretion remains preserved (governed by the renin-angiotensin system).
• Severe Hypothyroidism: Profound myxedema diminishes cardiac output and glomerular filtration rate, provoking baroreceptor-mediated non-osmotic ADH release.

C. Hypervolemic Hyponatremia

Characterized by an expansion of total body sodium accompanied by a disproportionately greater increase in total body water, resulting in overt peripheral edema, pulmonary congestion, or ascites.

• Decreased Effective Circulating Arterial Volume (Urine Na+ < 20 mmol/L, FENa < 1%):
  • Congestive Heart Failure (CHF), Decompensated Cirrhosis, and Nephrotic Syndrome.
  • Pathophysiology: Reduced cardiac output or splanchnic arterial vasodilation decreases effective arterial perfusion pressure. Carotid sinus and renal baroreceptors sense this arterial underfilling, triggering massive non-osmotic ADH release and activating the renin-angiotensin-aldosterone axis. Despite severe total body fluid overload, the kidneys retain sodium and water avidly; water retention exceeds sodium retention, generating dilutional hyponatremia.
• Renal Failure (Urine Na+ > 20 mmol/L, FENa > 1%):
  • Acute kidney injury or end-stage chronic kidney disease; damaged tubular nephrons are physiologically incapable of generating dilute urine or clearing free water.

+-----------------------------------------------------------------------------------------+
|                    Differential Diagnostic Table: Hyponatremia Subtypes                 |
+-----------------------------------------------------------------------------------------+
| Classification     ECF Volume  Urine Na+    Urine Osm      Primary Clinical Etiologies  |
+-----------------------------------------------------------------------------------------+
| Hypovolemic        Decreased   < 20 mmol/L  > 400 mOsm/kg  Vomiting, diarrhea, burns,   |
| (Extra-renal loss)                                         third-spacing (pancreatitis) |
|                                                                                         |
| Hypovolemic        Decreased   > 20 mmol/L  < 350 mOsm/kg  Thiazide diuretics, Addison  |
| (Renal loss)                                               disease, cerebral salt wastg |
|                                                                                         |
| Euvolemic          Normal      > 20-40 mmol > 100 mOsm/kg  SIADH (malignancy, CNS/lung) |
| (SIADH)                                     (inapprop. ^)  Glucocorticoid deficiency    |
|                                                                                         |
| Euvolemic          Normal      < 20 mmol/L  < 100 mOsm/kg  Psychogenic polydipsia, beer |
| (Polydipsia)                                (maximally v)  potomania, low-solute diet   |
|                                                                                         |
| Hypervolemic       Increased   < 20 mmol/L  > 400 mOsm/kg  Congestive heart failure,    |
| (Edematous states) (Edema/JVD)                             cirrhosis, nephrotic syndr.  |
|                                                                                         |
| Hypervolemic       Increased   > 20 mmol/L  Variable       Acute kidney injury (AKI),   |
| (Renal failure)    (Edema/JVD)              (~300 isosth.) End-stage renal disease (ESRD|
+-----------------------------------------------------------------------------------------+

Neurological Complications: Cerebral Edema vs Osmotic Demyelination Syndrome

• Acute Hyponatremia (<48 hours): When serum sodium drops precipitously, hypotonic plasma drives immediate osmotic water movement across the blood-brain barrier into brain astrocytes via aquaporin-4 channels. The resulting cerebral edema increases intracranial pressure, producing headache, nausea, projectile vomiting, obtundation, tonic-clonic seizures, tentorial herniation, and death.
• Chronic Hyponatremia (>48 hours): To defend cell volume, cerebral astrocytes adapt by extruding intracellular electrolytes (K+ and Cl-) within hours, followed by the slow expulsion of organic osmolytes (myo-inositol, betaine, glutamate, and taurine) over 24 to 48 hours, returning brain water content toward normal.
• Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis): If chronic hyponatremia is corrected too rapidly (> 8 to 10 mmol/L in 24 hours, or > 18 mmol/L in 48 hours), the hypertonic extracellular environment pulls water out of adapted astrocytes and oligodendrocytes faster than they can resynthesize organic osmolytes. The cells dehydrate, undergo apoptosis, and their myelin sheaths rupture. Clinical manifestations appear 2 to 6 days after rapid correction, presenting with pseudobulbar palsy, dysarthria, dysphagia, horizontal gaze paralysis, spastic quadriparesis, locked-in syndrome, and coma.

---

Hypernatremia (>145 mmol/L)

Hypernatremia is defined as a serum sodium concentration exceeding 145 mmol/L. Because sodium is the primary extracellular cation, hypernatremia always denotes hyperosmolality / hypertonicity (> 295 mOsm/kg). Thirst is the primary physiological defense mechanism against hypernatremia; consequently, sustained hypernatremia occurs almost exclusively in individuals unable to perceive or respond to thirst (infants, intubated patients, elderly individuals with hypodipsia, and obtunded patients).

Etiologies of Hypernatremia

1. Pure Water Loss: Unreplaced insensible losses (prolonged high fever, respiratory tract hyperventilation, thermal burns), hypodipsia (adipsic hypernatremia due to hypothalamic osmoreceptor damage).
2. Hypotonic Fluid Loss: Gastrointestinal losses (osmotic diarrhea, lactulose administration), cutaneous losses (strenuous exercise), renal losses (osmotic diuresis induced by uncontrolled hyperglycemia in hyperglycemic hyperosmolar state [HHS], urea, or intravenous mannitol).
3. Hypertonic Sodium Gain: Iatrogenic administration of hypertonic 3% sodium chloride, excessive sodium bicarbonate ampules during cardiopulmonary resuscitation, or primary hyperaldosteronism (Conn syndrome). In Conn syndrome, autonomous aldosterone overproduction causes mild hypernatremia (146-150 mmol/L phases), profound hypokalemia, and metabolic alkalosis, with suppressed plasma renin activity.

Diabetes Insipidus (DI): Central vs Nephrogenic

Diabetes insipidus is characterized by an inability to concentrate urine, leading to polyuria (> 3 to 4 L/day in adults), polydipsia, and an inappropriately dilute urine (< 300 mOsm/kg) despite elevated plasma osmolality:

• Central (Neurogenic) Diabetes Insipidus: Impaired synthesis, transport, or secretion of ADH by the hypothalamic-neurohypophyseal system. Causes include pituitary adenomas, craniopharyngiomas, neurosurgery (transsphenoidal hypophysectomy), severe head trauma, infiltrative granulomas (sarcoidosis, histiocytosis X), and autoimmune infundibulo-neurohypophysitis.
• Nephrogenic Diabetes Insipidus: Adequate circulating concentrations of ADH, but renal collecting duct principal cells exhibit end-organ resistance to ADH action.
  • Congenital: Recessive mutations in the vasopressin V2 receptor gene (AVPR2, X-linked recessive, 90% of congenital cases) or aquaporin-2 gene (AQP2, autosomal recessive).
  • Acquired: Chronic Lithium Therapy (lithium enters principal cells through ENaC, inhibits glycogen synthase kinase-3 beta [GSK-3beta], and downregulates AQP2 expression), severe hypokalemia, hypercalcemia (activates calcium-sensing receptors, disrupting counter-current multiplier and AQP2 shuttling), and demeclocycline administration.

The Water Deprivation Test & Desmopressin (dDAVP) Challenge

The standard clinical protocol for differentiating central DI, nephrogenic DI, and primary polydipsia is the Water Deprivation Test followed by the administration of Desmopressin (dDAVP), a synthetic vasopressin analogue:

+-----------------------------------------------------------------------------------------+
|               Water Deprivation Test and dDAVP Response Interpretation                  |
+-----------------------------------------------------------------------------------------+
| Clinical Condition      Urine Osmolality after Dehydration    Response to Exogenous dDAVP|
+-----------------------------------------------------------------------------------------+
| Normal Individual       Urine concentrates appropriately      Minimal increase (<10%)   |
|                         (> 800 mOsm/kg)                       (Maximal ADH already endog)|
|                                                                                         |
| Primary Polydipsia      Concentrates moderately               Minimal increase (<10%)   |
| (Psychogenic)           (500 - 800 mOsm/kg; medullary wash)   (Endogenous ADH intact)   |
|                                                                                         |
| Central Diabetes        Remains persistently dilute           DRAMATIC INCREASE (>50%)  |
| Insipidus (Neurogenic)  (< 300 mOsm/kg; urine Osm < plasma)   (Rises to > 600 mOsm/kg)  |
|                                                                                         |
| Nephrogenic Diabetes    Remains persistently dilute           NO SIGNIFICANT RESPONSE   |
| Insipidus               (< 300 mOsm/kg; refractory to thirst) (< 45-50% increase;       |
|                                                               remains dilute < 400 mOsm)|
+-----------------------------------------------------------------------------------------+

During fluid deprivation, the patient's weight, serum osmolality, and urine osmolality are monitored hourly until serum osmolality exceeds 295 mOsm/kg or urine osmolality plateaus across three consecutive measurements. Subcutaneous or intranasal desmopressin (dDAVP) is then administered:

• In Central DI, the collecting duct principal cells are fully sensitive to vasopressin. The administration of exogenous dDAVP triggers immediate AQP2 insertion, causing urine osmolality to increase by > 50% (frequently > 100%), demonstrating restoration of urinary concentrating capability.
• In Nephrogenic DI, the renal collecting duct epithelium is unresponsive to vasopressin. Exogenous dDAVP produces minimal or no increase in urine osmolality (< 45-50%, rarely exceeding 300 to 400 mOsm/kg), confirming end-organ receptor or post-receptor defect.